Natera Signatera, Altera, and Empower tests
About
Gather distinctive biomarkers that can guide treatment and monitor disease progression
Liquid biopsy: gather and analyze blood and other bodily liquids (urine, bone marrow aspirate, saliva) for biomarkers (e.g., PSA, DNA, RNA, proteins), including minimum residual disease monitoring and early detection
Coverage & Insurance
Accepted
Available
Required
In-network carriers
Cancer types served
Related Providers
BostonGene
5 offeringsProvide an integrated profile of the disease at maximum depth to identify novel personalized treatment options and guide strategy and decisions
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Protean Biodiagnostics
3 offeringsIdentify the best treatment ideas using the best global thinking, predict treatment response, assess confidence in outcome
Get personalized guidance for your case
This is general information. Upload your records for analysis specific to YOUR diagnosis.